Soroosh Kiani is a Cardiology physician affiliated with University of Massachusetts Chan Medical School. OpenAlex indexes 69 publications with 863 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Perclose Multi-Access Duplex Ultrasound (DUS) Study
Sponsor: Abbott Medical Devices
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Abbott LaboratoriesProgram year20245 payments
- Medtronic, Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
60.5%Beta blocker28.9%Metoprolol Succinate60%Metoprolol Tartrate24%Carvedilol16%Part D≥47 patientsCalcium channel blocker12.4%Diltiazem 24hr Er (Cd)43%Amlodipine Besylate40%Diltiazem Hcl17%Part D<11 patients+ 4 more classes in this area
Blood & clotting
39.5%Factor Xa inhibitor39.5%Eliquis88%Xarelto12%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sex Disparities in Atrial Fibrillation and Atrial Flutter Presentation, Treatment, and Outcomes in Reproductive‐Aged Individuals
Journal of Cardiovascular Electrophysiology
2026 - 26-CCC-17516-ACC A SHOCKING CAUSE OF ISCHEMIA: IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR (ICD) LEAD OBSTRUCTING CORONARY ARTERY FLOW
Journal of the American College of Cardiology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Kimberly Yonkers, MD
University of Massachusetts Chan Medical School
Richard Irwin, MD
University of Massachusetts Chan Medical School
Craig Lilly, MD
University of Massachusetts Chan Medical School
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”